ImmuCell Corporation

NASDAQ: ICCC · Real-Time Price · USD
6.09
-0.63 (-9.38%)
At close: Aug 15, 2025, 3:59 PM
6.19
1.64%
After-hours: Aug 15, 2025, 04:10 PM EDT

ImmuCell Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-2.16M -5.77M -2.49M -78.29K
Depreciation & Amortization
2.69M 2.72M 2.49M 2.46M
Stock-Based Compensation
326K 368.87K 266.24K 144.31K
Other Working Capital
n/a -2.43M 179.9K -245.49M
Other Non-Cash Items
1.83M 260.82K 28.8K 18.56K
Deferred Income Tax
n/a n/a n/a 30.96K
Change in Working Capital
n/a -2.27M -1.83M -1.62M
Operating Cash Flow
357.9K -4.67M -1.54M 954.17K
Capital Expenditures
-465.73K -1.89M -3.98M -2.61M
Cash Acquisitions
n/a n/a 11K 15.29K
Purchase of Investments
n/a n/a n/a -15.29K
Sales Maturities Of Investments
n/a n/a n/a 996K
Other Investing Acitivies
-461.23K 2.47K 11K 15.29K
Investing Cash Flow
-461.23K -1.89M -3.96M -1.6M
Debt Repayment
-1.47M 1.81M 1.1M -368.27K
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
-5.04K -62.77K 11.36K 13.96K
Financial Cash Flow
2.88M 1.75M 1.11M 3.88M
Net Cash Flow
-978.74K -4.81M -4.39M 3.24M
Free Cash Flow
-107.82K -6.57M -5.52M -1.65M